2 results match your criteria: "Centre for Pancreatic Diseases at the McGill University Health Centre[Affiliation]"
Islet neogenesis: a potential therapeutic tool in type 1 diabetes.
Int J Biochem Cell Biol
May 2006
Centre for Pancreatic Diseases at the McGill University Health Centre, Department of Surgery, McGill Uinversity, Montreal, Canada.
Current therapies for type 1 diabetes, including fastidious blood glucose monitoring and multiple daily insulin injections, are not sufficient to prevent complications of the disease. Though pancreas and possibly islet transplantation can prevent the progression of complications, the scarcity of donor organs limits widespread application of these approaches. Understanding the mechanisms of beta-cell mass expansion as well as the means to exploit these pathways has enabled researchers to develop new strategies to expand and maintain islet cell mass.
View Article and Find Full Text PDFIslet neogenesis: a potential therapeutic tool in type 1 diabetes.
Int J Biochem Cell Biol
June 2006
Centre for Pancreatic Diseases at the McGill University Health Centre, Department of Surgery, McGill University, C9-128 Montreal General Hospital, 1650 Cedar Avenue, Montreal, Que., Canada.
Current therapies for type 1 diabetes, including fastidious blood glucose monitoring and multiple daily insulin injections, are not sufficient to prevent complications of the disease. Though pancreas and possibly islet transplantation can prevent the progression of complications, the scarcity of donor organs limits widespread application of these approaches. Understanding the mechanisms of beta-cell mass expansion as well as the means to exploit these pathways has enabled researchers to develop new strategies to expand and maintain islet cell mass.
View Article and Find Full Text PDF